Eligibility of patients with type 2 diabetes for sodium–glucose cotransporter 2 inhibitor cardiovascular outcomes trials: a global perspective from the DISCOVER study

OBJECTIVE: To assess the eligibility of patients participating in DISCOVER (a 3-year, prospective, observational study program of 15 992 patients with type 2 diabetes [T2D] initiating a second-line glucose-lowering therapy across 38 countries) for four cardiovascular outcomes trials (CVOTs) of sodiu...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:BMJ Open Diabetes Res Care
Asıl Yazarlar: Pintat, Stéphane, Fenici, Peter, Hammar, Niklas, Ji, Linong, Khunti, Kamlesh, Medina, Jesús, Tang, Fengming, Wittbrodt, Eric, Surmont, Filip
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BMJ Publishing Group 2019
Konular:
Epidemiology/Health Services Research
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6501855/
https://ncbi.nlm.nih.gov/pubmed/31114700
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjdrc-2018-000627
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller